keyword
https://read.qxmd.com/read/38626384/associations-between-blood-based-biomarkers-and-cognitive-and-functional-trajectories-among-participants-of-the-memento-cohort
#1
JOURNAL ARTICLE
Leslie Grasset, Vincent Bouteloup, Federica Cacciamani, Isabelle Pellegrin, Vincent Planche, Geneviève Chêne, Carole Dufouil
BACKGROUND AND OBJECTIVES: Elevated levels of Alzheimer disease (AD) blood-based biomarkers are associated with accelerated cognitive decline. However, their distinct relationships with specific cognitive and functional domains require further investigation. We aimed at estimating the associations between AD blood-based biomarkers and the trajectories of distinct cognitive and functional domains over a 5-year follow-up period. METHODS: We conducted a clinic-based prospective study using data from the MEMENTO study, a nationwide French cohort...
May 2024: Neurology
https://read.qxmd.com/read/38626359/trajectories-of-inflammatory-markers-and-post-covid-19-cognitive-symptoms-a-secondary-analysis-of-the-contain-covid-19-randomized-trial
#2
JOURNAL ARTICLE
Jennifer A Frontera, Rebecca A Betensky, Liise-Anne Pirofski, Thomas Wisniewski, Hyunah Yoon, Mila B Ortigoza
BACKGROUND AND OBJECTIVES: Chronic systemic inflammation has been hypothesized to be a mechanistic factor leading to post-acute cognitive dysfunction after COVID-19. However, little data exist evaluating longitudinal inflammatory markers. METHODS: We conducted a secondary analysis of data collected from the CONTAIN randomized trial of convalescent plasma in patients hospitalized for COVID-19, including patients who completed an 18-month assessment of cognitive symptoms and PROMIS Global Health questionnaires...
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38625863/generating-pet-scan-patterns-in-alzheimer-s-by-a-mathematical-model
#3
JOURNAL ARTICLE
Chaeyoung Lee, Avner Friedman
Alzheimer disease (AD) is the most common form of dementia. The cause of the disease is unknown, and it has no cure. Symptoms include cognitive decline, memory loss, and impairment of daily functioning. The pathological hallmarks of the disease are aggregation of plaques of amyloid-β (Aβ) and neurofibrillary tangles of tau proteins (τ), which can be detected in PET scans of the brain. The disease can remain asymptomatic for decades, while the densities of Aβ and τ continue to grow...
2024: PloS One
https://read.qxmd.com/read/38624088/peripheral-hmgb1-is-linked-to-o-3-pathology-of-disease-associated-astrocytes-and-amyloid
#4
JOURNAL ARTICLE
Chandrama Ahmed, Hendrik J Greve, Carla Garza-Lombo, Jamie A Malley, James A Johnson, Adrian L Oblak, Michelle L Block
INTRODUCTION: Ozone (O3 ) is an air pollutant associated with Alzheimer's disease (AD) risk. The lung-brain axis is implicated in O3 -associated glial and amyloid pathobiology; however, the role of disease-associated astrocytes (DAAs) in this process remains unknown. METHODS: The O3 -induced astrocyte phenotype was characterized in 5xFAD mice by spatial transcriptomics and proteomics. Hmgb1fl/fl LysM-Cre+ mice were used to assess the role of peripheral myeloid cell high mobility group box 1 (HMGB1)...
April 16, 2024: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
https://read.qxmd.com/read/38624069/anxiety-in-alzheimer-s-disease-rats-is-independent-of-memory-and-impacted-by-genotype-age-sex-and-exercise
#5
JOURNAL ARTICLE
Danielle C Lopez, Zachary J White, Stephanie E Hall
INTRODUCTION: Alzheimer's disease (AD) is characterized by cognitive impairments; however, heightened anxiety often accompanies and, in some cases, exacerbates cognitive its. The present study aims to understand the influence of multiple variables on anxiety-like behavior in TgF344-AD rats and determine whether anxiety impacts memory performance. METHODS: An elevated plus maze was used to assess anxiety-like behavior in the established colony (n = 107)...
April 16, 2024: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
https://read.qxmd.com/read/38623985/the-postoperative-effects-of-anesthesia-exposure-on-cognitive-decline-in-older-adults-a-narrative-review
#6
JOURNAL ARTICLE
Kathleen Angela Willoughby-Dudley, Marielle L Darwin, Deana B Davalos
BACKGROUND: As modern medicine continues to make strides in effective surgical treatments, we must also consider the critical impact of anesthesia on neuropsychological outcomes. Recent evidence suggests that anesthesia exposure may be a risk factor for postoperative cognitive decline and the eventual development of dementia. OBJECTIVES: To explore the vulnerability of the aging brain in the context of anesthesia exposure in surgery, studies will be reviewed, and pertinent findings will be highlighted and explored to better understand risks and possible factors that need to be considered when contemplating surgery...
April 15, 2024: Current Alzheimer Research
https://read.qxmd.com/read/38623902/-not-available
#7
JOURNAL ARTICLE
Maurice Pasternak, Saira S Mirza, Nicholas Luciw, Henri J M M Mutsaerts, Jan Petr, David Thomas, David Cash, Martina Bocchetta, Maria Carmela Tartaglia, Sara B Mitchell, Sandra E Black, Morris Freedman, David Tang-Wai, Ekaterina Rogaeva, Lucy L Russell, Arabella Bouzigues, John C van Swieten, Lize C Jiskoot, Harro Seelaar, Robert Laforce, Pietro Tiraboschi, Barbara Borroni, Daniela Galimberti, James B Rowe, Caroline Graff, Elizabeth Finger, Sandro Sorbi, Alexandre de Mendonça, Chris Butler, Alex Gerhard, Raquel Sanchez-Valle, Fermin Moreno, Matthis Synofzik, Rik Vandenberghe, Simon Ducharme, Johannes Levin, Markus Otto, Isabel Santana, Antonio P Strafella, Bradley J MacIntosh, Jonathan D Rohrer, Mario Masellis
INTRODUCTION: Effective longitudinal biomarkers that track disease progression are needed to characterize the presymptomatic phase of genetic frontotemporal dementia (FTD). We investigate the utility of cerebral perfusion as one such biomarker in presymptomatic FTD mutation carriers. METHODS: We investigated longitudinal profiles of cerebral perfusion using arterial spin labeling magnetic resonance imaging in 42 C9orf72, 70 GRN, and 31 MAPT presymptomatic carriers and 158 non-carrier controls...
April 16, 2024: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
https://read.qxmd.com/read/38623856/cognitive-impairment-neurodegenerative-disorders-and-olfactory-impairment-a-literature-review
#8
REVIEW
Martina Kovalová, Nikol Gottfriedová, Eva Mrázková, Vladimír Janout, Jana Janoutová
<br><b>Introduction:</b> The early detection and diagnosis of dementia are of key importance in treatment, slowing disease progression, or suppressing symptoms. The possible role of changes in the sense of smell is considered with regard to potential markers for early detection of Alzheimer's disease (AD).</br> <br><b>Materials and methods:</b> A literature search was conducted using the electronic databases PubMed, Scopus, and Web of Science between May 30, 2022 and August 2, 2022...
April 9, 2024: Otolaryngologia Polska
https://read.qxmd.com/read/38623717/positive-emotional-responses-to-socially-assistive-robots-in-people-with-dementia-pilot-study
#9
JOURNAL ARTICLE
Eri Otaka, Aiko Osawa, Kenji Kato, Yota Obayashi, Shintaro Uehara, Masaki Kamiya, Katsuhiro Mizuno, Shusei Hashide, Izumi Kondo
BACKGROUND: Interventions and care that can evoke positive emotions and reduce apathy or agitation are important for people with dementia. In recent years, socially assistive robots used for better dementia care have been found to be feasible. However, the immediate responses of people with dementia when they are given multiple sensory modalities from socially assistive robots have not yet been sufficiently elucidated. OBJECTIVE: This study aimed to quantitatively examine the immediate emotional responses of people with dementia to stimuli presented by socially assistive robots using facial expression analysis in order to determine whether they elicited positive emotions...
April 11, 2024: JMIR aging
https://read.qxmd.com/read/38623695/impact-of-the-pandemic-on-dementia-care-and-caregivers-a-qualitative-study
#10
JOURNAL ARTICLE
Juan Francisco Velarde-García, Carmen Ortego-Maté, Carmen Sarabia-Cobo, Aroa Delgado Uria, Rosario Fernández-Peña
Physical distancing measures to limit contagion in the COVID-19 pandemic made it difficult to care for older persons with dementia. Non-essential home visits were prevented and family caregivers took over most of their care. The aim of our study was to describe the lived experience of peoples living with dementia caregivers during the pandemic regarding the care provided and the person cared for. A qualitative phenomenological design was used. Participants were recruited using purposeful sampling. Informants were selected from primary healthcare centers, day centers, and a community mental health unit...
April 16, 2024: Clinical Nursing Research
https://read.qxmd.com/read/38623387/relationship-of-plasma-biomarkers-to-digital-cognitive-tests-in-alzheimer-s-disease
#11
JOURNAL ARTICLE
Sofia Toniolo, Sijia Zhao, Anna Scholcz, Benazir Amein, Akke Ganse-Dumrath, Amanda J Heslegrave, Sian Thompson, Sanjay Manohar, Henrik Zetterberg, Masud Husain
INTRODUCTION: A major limitation in Alzheimer's disease (AD) research is the lack of the ability to measure cognitive performance at scale-robustly, remotely, and frequently. Currently, there are no established online digital platforms validated against plasma biomarkers of AD. METHODS: We used a novel web-based platform that assessed different cognitive functions in AD patients ( N  = 46) and elderly controls ( N  = 53) who were also evaluated for plasma biomarkers (amyloid beta 42/40 ratio, phosphorylated tau ([p-tau]181, glial fibrillary acidic protein, neurofilament light chain)...
2024: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
https://read.qxmd.com/read/38623386/extending-the-phenotypic-spectrum-assessed-by-the-cdr-plus-nacc-ftld-in-genetic-frontotemporal-dementia
#12
JOURNAL ARTICLE
Kiran Samra, Georgia Peakman, Amy M MacDougall, Arabella Bouzigues, Caroline V Greaves, Rhian S Convery, John C van Swieten, Lize Jiskoot, Harro Seelaar, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonça, Chris R Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Pietro Tiraboschi, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jonathan D Rohrer, Lucy L Russell
INTRODUCTION: We aimed to expand the range of the frontotemporal dementia (FTD) phenotypes assessed by the Clinical Dementia Rating Dementia Staging Instrument plus National Alzheimer's Coordinating Center Behavior and Language Domains (CDR plus NACC FTLD). METHODS: Neuropsychiatric and motor domains were added to the standard CDR plus NACC FTLD generating a new CDR plus NACC FTLD-NM scale. This was assessed in 522 mutation carriers and 310 mutation-negative controls from the Genetic Frontotemporal dementia Initiative (GENFI)...
2024: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
https://read.qxmd.com/read/38623385/risk-of-depression-in-persons-with-alzheimer-s-disease-a-national-cohort-study
#13
JOURNAL ARTICLE
Casey Crump, Weiva Sieh, Barbara G Vickrey, Alexis C Edwards, Jan Sundquist, Kristina Sundquist
INTRODUCTION: Depression is a risk factor and possible prodromal symptom of Alzheimer's disease (AD), but little is known about subsequent risk of developing depression in persons with AD. METHODS: National matched cohort study was conducted of all 129,410 persons diagnosed with AD and 390,088 with all-cause dementia during 1998-2017 in Sweden, and 3,900,880 age- and sex-matched controls without dementia, who had no prior depression. Cox regression was used to compute hazard ratios (HRs) for major depression through 2018...
2024: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
https://read.qxmd.com/read/38623384/cognitive-and-functional-performance-and-plasma-biomarkers-of-early-alzheimer-s-disease-in-down-syndrome
#14
JOURNAL ARTICLE
Emily K Schworer, Benjamin L Handen, Melissa Petersen, Sid O'Bryant, Jamie C Peven, Dana L Tudorascu, Laisze Lee, Sharon J Krinsky-McHale, Christy L Hom, Isabel C H Clare, Bradley T Christian, Nicole Schupf, Joseph H Lee, Elizabeth Head, Mark Mapstone, Ira Lott, Beau M Ances, Shahid Zaman, Adam M Brickman, Florence Lai, H Diana Rosas, Sigan L Hartley
INTRODUCTION: People with Down syndrome (DS) have a 75% to 90% lifetime risk of Alzheimer's disease (AD). AD pathology begins a decade or more prior to onset of clinical AD dementia in people with DS. It is not clear if plasma biomarkers of AD pathology are correlated with early cognitive and functional impairments in DS, and if these biomarkers could be used to track the early stages of AD in DS or to inform inclusion criteria for clinical AD treatment trials. METHODS: This large cross-sectional cohort study investigated the associations between plasma biomarkers of amyloid beta (Aβ)42/40, total tau, and neurofilament light chain (NfL) and cognitive (episodic memory, visual-motor integration, and visuospatial abilities) and functional (adaptive behavior) impairments in 260 adults with DS without dementia (aged 25-81 years)...
2024: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
https://read.qxmd.com/read/38623383/from-understanding-to-action-exploring-molecular-connections-of-down-syndrome-to-alzheimer-s-disease-for-targeted-therapeutic-approach
#15
REVIEW
Sonal Sukreet, Michael S Rafii, Robert A Rissman
Down syndrome (DS) is caused by a third copy of chromosome 21. Alzheimer's disease (AD) is a neurodegenerative condition characterized by the deposition of amyloid-beta (Aβ) plaques and neurofibrillary tangles in the brain. Both disorders have elevated Aβ, tau, dysregulated immune response, and inflammation. In people with DS, Hsa21 genes like APP and DYRK1A are overexpressed, causing an accumulation of amyloid and neurofibrillary tangles, and potentially contributing to an increased risk of AD...
2024: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
https://read.qxmd.com/read/38623117/when-the-stomach-takes-a-vacation-the-unseen-battles-of-gastroparesis
#16
Beatriz R Sousa, Teresa B Rodrigues, José Ribeiro
Gastroparesis is a syndrome characterised by delayed gastric emptying that is usually idiopathic, diabetic, or iatrogenic. This underdiagnosed disease has a substantial influence on the quality of life of its patients. We present the case of an 86-year-old man with dementia, benign prostatic hyperplasia, and gastroesophageal reflux disease who developed symptoms of gastroparesis during a lengthy hospital stay. Computed tomography (CT) and upper digestive endoscopy demonstrated gastric distention and pyloric stenosis...
March 2024: Curēus
https://read.qxmd.com/read/38623057/the-impact-on-employment-and-education-of-caregiving-for-a-family-member-with-young-onset-dementia-a-scoping-review
#17
JOURNAL ARTICLE
Kristina M Kokorelias, Nirusa Nadesar, Katherine Bak, Jennifer Boger, Louise Nygård, Anna Mäki-Petäjä-Leinonen, Ann-Charlotte Nedlund, Arlene Astell
Young-onset dementia (YOD) affects individuals under 65 years of age, often leading to loss of employment and independence. Families provide increasing levels of care to family members with YOD, resulting in changes to their daily lives, including their occupational pursuits. This review examines evidence of the occupational implications for family members who provide care to a family with YOD to identify: (i) the influence and impact caregiving tasks and responsibilities have on employment, volunteering, and education, and (ii) caregiver, and caregiving situation factors associated with changes in employment, volunteering, and education...
April 16, 2024: Dementia
https://read.qxmd.com/read/38622902/historical-review-the-golden-age-of-the-golgi-method-in-human-neuropathology
#18
JOURNAL ARTICLE
Isidro Ferrer
Golgi methods were used to study human neuropathology in the 1970s, 1980s, and 1990s of the last century. Although a relatively small number of laboratories applied these methods, their impact was crucial by increasing knowledge about: (1) the morphology, orientation, and localization of neurons in human cerebral and cerebellar malformations and ganglionic tumors, and (2) the presence of abnormal structures including large and thin spines (spine dysgenesis) in several disorders linked to mental retardation, focal enlargements of the axon hillock and dendrites (meganeurites) in neuronal storage diseases, growth cone-like appendages in Alzheimer disease, as well as abnormal structures in other dementias...
April 15, 2024: Journal of Neuropathology and Experimental Neurology
https://read.qxmd.com/read/38622754/safety-profile-of-hypnotics-or-sedatives-on-community-dwelling-older-adults-aged-75-or-older-in-japan-a-retrospective-propensity-matched-cohort-study
#19
JOURNAL ARTICLE
Nobuhiro Handa, Tatsuro Ishizaki, Seigo Mitsutake, Koki Ono, Masahiro Akishita
OBJECTIVE: The purpose of the study is to assess if daily use of hypnotics increases mortality, aspiration pneumonia and hip fracture among relatively healthy individuals aged 75 years or older who lead independent lives in the community. METHOD AND PATIENTS: Of the adults aged 75 years or older residing in Hokkaido prefecture of Japan (n = 705,538), those who did not meet several exclusion criteria were eligible for generating propensity score-matched cohorts (n = 214,723)...
April 2024: International Journal of Geriatric Psychiatry
https://read.qxmd.com/read/38622654/immunotherapy-with-an-antibody-against-cd1d-modulates-neuroinflammation-in-an-%C3%AE-synuclein-transgenic-model-of-lewy-body-like-disease
#20
JOURNAL ARTICLE
Michiyo Iba, Somin Kwon, Changyoun Kim, Marcell Szabo, Liam Horan-Portelance, Maria Lopez-Ocasio, Pradeep Dagur, Cassia Overk, Robert A Rissman, Eliezer Masliah
The neuroinflammatory process in synucleinopathies of the aging population such as Parkinson's disease (PD) and dementia with Lewy bodies (DLB) involves microglial activation as well as infiltration of the CNS by T cells and natural killer T cells (NKTs). To evaluate the potential of targeting NKT cells to modulate neuroinflammation, we treated α-syn transgenic (tg) mice (e.g.: Thy1 promoter line 61) with an antibody against CD1d, which is a glycoprotein expressed in antigen presenting cells (APCs). CD1d-presented lipid antigens activate NKT cells through the interaction with T cell receptor in NKTs, resulting in the production of cytokines...
April 15, 2024: Journal of Neuroinflammation
keyword
keyword
117310
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.